<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="95694">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01812356</url>
  </required_header>
  <id_info>
    <org_study_id>2012-11-088</org_study_id>
    <nct_id>NCT01812356</nct_id>
  </id_info>
  <brief_title>The Concomitant Cryomaze Procedure Using Nitreous Oxide Cryoprobe: Comparison With Argon Based Cryoprobe</brief_title>
  <official_title>Study of Cryomaze Procedure Using Nitrous Oxide Versus Argon Gas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators have used the Medtronic ATS cryoprobe (Argon based) since 2009 for
      cryomaze procedure for treatment of atrial fibrillation combined with valvular heart
      disease.

      However, sometimes, it was inconvenient due to excess flexibility, wide lesion related to
      excess low temperature and time-consuming detachment from atrium after cryoablation. The
      investigators introduced Atricure cryoprobe (Nitreos Oxide based) in hope of overcoming
      these shortcomings of ATS probes last year.

      Up to date, the investigators have been satisfactory in terms of the surgical convenience.
      On the other hand, we have the questionability of transmural lesion of Atricure probe
      because of the higher temperature of Atricure probe compared with ATS probe.

      The aim of this study is compare the surgical convenience and early and long-term outcomes
      of cryomaze procedure using nitrous oxide with using Argon gas.

      The investigators will analyze the pathologic findings of atrial tissue after cryoablation
      using two probes and early and long-term outcomes with Holter monitoring. Atrial
      fibrillation burden 3 months and 1 year postoperatively and atrial activity will be checked.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>recurrence of atrial fibrillation</measure>
    <time_frame>one year</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Valve</condition>
  <arm_group>
    <arm_group_label>Argon gas probe</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cryomaze procedure using Argon gas probe</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nitrous oxide probe</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cryomaze procedure using Nitrous oxide probe</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cryomaze procedure using Nitrous oxide</intervention_name>
    <arm_group_label>Nitrous oxide probe</arm_group_label>
    <other_name>Atricure cryoprobe</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cryomaze procedure using Argon</intervention_name>
    <arm_group_label>Argon gas probe</arm_group_label>
    <other_name>ATS medtronic probe</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  requiring concomitant maze operation with valve surgery (persistent atrial
             fibrillation)

          -  between 30 and 70 years old

        Exclusion Criteria:

          -  previous cardiac surgery

          -  Behcet disease

          -  Takayasu's arteritis

          -  Infective endocarditis

          -  Congenital heart disease

          -  left atrial size over 80mm

          -  moderate or greater functional tricuspid regurgitation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pwo Won Park, MD, PhD</last_name>
    <phone>82-2-3410-3481</phone>
    <email>pwpark@skku.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pyo Won Park, MD,PhD</last_name>
      <phone>82-2-3410-3481</phone>
      <email>pwpark@skku.edu</email>
    </contact>
    <investigator>
      <last_name>Dong Seop Jeong, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 13, 2013</lastchanged_date>
  <firstreceived_date>March 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>maze operation</keyword>
  <keyword>cryoablation</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nitrous Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
